NCT01085552View on ClinicalTrials.gov

Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Chronic Kidney FailureAnaemia
Interventions
DRUG

Epoetin Beta

Epoetin Beta. A single subcutaneous dose of 50IU/kg on Day 1. The body weight recording on day -1 will be used to calculate the dosage

Sponsors
All Listed Sponsors
lead

InCROM Europe Clinical Research

INDUSTRY